生物技术公司Arcturus Therapeutics Ltd. (ARCT) 已正式宣布,计划于2026年3月3日发布其2025财年第四季度及全年的财务业绩报告。此次发布将详细披露公司在指定财季及整个财年的财务表现。此外,管理层将同步举行公司业务更新会议,向投资者和市场参与者介绍最新的运营进展与战略规划。
生物技术公司Arcturus Therapeutics Ltd. (ARCT) 已正式宣布,计划于2026年3月3日发布其2025财年第四季度及全年的财务业绩报告。此次发布将详细披露公司在指定财季及整个财年的财务表现。此外,管理层将同步举行公司业务更新会议,向投资者和市场参与者介绍最新的运营进展与战略规划。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.